--- title: "Eric Cantor named president and CEO of PhRMA" publication: "MediaBias News" url: "https://mediabias.news/politics/eric-cantor-named-president-and-ceo-of-phrma" api: "https://mediabias.news/api/v1/stories/eric-cantor-named-president-and-ceo-of-phrma" markdown: "https://mediabias.news/politics/eric-cantor-named-president-and-ceo-of-phrma.md" audio: "https://mediabias.news/api/audio/eric-cantor-named-president-and-ceo-of-phrma" category: "Politics" area: "United States" published: "2026-09-29T22:25:27.419Z" source_reported: "2026-09-29T21:05:28.000Z" updated: "2026-09-29T22:25:27.419Z" trust_score: 42 critic_score: 57 hype_score: 41 assessment_type: "coverage-and-source-reporting-analysis" fact_check_status: "not-performed" coverage_measured: "2026-09-29T23:30:29.797714+00:00" --- # Eric Cantor named president and CEO of PhRMA *The former House majority leader will lead the pharmaceutical lobbying group.* **Scores for the source reporting** (0-100, assessing the original journalism this article was written from, not this write-up): - Trust 42 of 100, higher is better. One outlet provided a full report, while 10 others provided digests, with limited independent corroboration. - Craft 57 of 100, higher is better. One outlet provided a full report with details on Cantor's voting record and industry funding. - Hype 41 of 100, lower is better. Some headlines used loaded language like 'Swamp Creatures' and 'Match Made in Hell'. Scored by MediaBias News; method at https://mediabias.news/methodology. **The short version** - Former US House Majority Leader Eric Cantor has been named president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA). - PhRMA spent $38 million on lobbying efforts, according to reports. - Peter Maybarduk of Public Citizen criticized Cantor's past legislative record on drug prices. - Cantor received approximately $900,000 from the pharmaceutical and health product industry during his time in Congress. Eric Cantor, former US House Majority Leader, has been appointed president and chief executive officer of the Pharmaceutical Research and Manufacturers of America (PhRMA). PhRMA is a lobbying group for the pharmaceutical industry. Cantor served in the US House of Representatives from 2001 to 2014, holding the position of House majority leader from 2011. The appointment comes at a time of significant public concern over the cost of prescription drugs. PhRMA has been actively lobbying on these issues, having spent $38 million on lobbying efforts, according to reports. The organization stated that Cantor's experience makes him suitable to lead during a critical period for the industry. Critics have raised concerns about Cantor's past legislative record. Peter Maybarduk, director of access to medicines at Public Citizen, stated that Cantor has a history of legislating in favour of corporations over working families. During his congressional tenure, Cantor received approximately $900,000 from the pharmaceutical and health product industry. Reports indicate he voted against legislation aimed at lowering prescription drug costs, including measures to allow importation of lower-cost drugs and to enable federal negotiation of Medicare drug prices. ## Coverage comparison ## What the coverage left out None of the right-rated digests mention the $38 million PhRMA spent on lobbying efforts. None of the centre-rated digests mention the $38 million PhRMA spent on lobbying efforts or the specific criticisms of Cantor's past legislative record regarding drug prices. ## Who covered it Shares of the 9 covering outlets with a published leaning rating: - Left: 11% (1) - Centre: 33% (3) - Right: 56% (5) 2 of 11 covering outlets carried no usable leaning rating and were excluded from those percentages. Coverage measured 2026-09-29T23:30:29.797714+00:00. **Coverage watch:** developing. Checked 6 times; 0 checks found a material change. Most recently checked 2026-09-29T23:45:24.379Z. ## How the sides framed it ### Left - Common Dreams, the sole left-rated report, led with the headline "'A Match Made in Hell': Former GOP House Leader to Head Big Pharma Lobby." The report highlighted criticism of Cantor's appointment, quoting Peter Maybarduk of Public Citizen who described Cantor as an "experienced reverse Robin Hood." The full report detailed Cantor's voting record against legislation to lower drug prices and noted the approximately $900,000 he received from the industry during his time in Congress. It also mentioned PhRMA's $38 million lobbying expenditure. ### Centre - The centre-rated reports from WTVB, STAT, and PR Newswire focused on the announcement of Eric Cantor's appointment as president and CEO of PhRMA. STAT noted that Cantor will face pressure on drug prices and increasing populism. PR Newswire's digest stated that Cantor was named by the Board of Directors of PhRMA. WTVB's digest, similar to regionalmedianews.com, reported the appointment based on information from Reuters. ### Right - The right-rated reports from the Washington Times, Breitbart, regionalmedianews.com, The Daily Caller, and thedailybs.com announced Eric Cantor's new role as CEO of PhRMA. The Daily Caller's headline referred to Cantor as "One Of The Biggest Swamp Creatures." Thedailybs.com noted that Cantor will assume the role effective November 9 and mentioned his tenure in the House of Representatives. Regionalmedianews.com and WTVB attributed the announcement to Reuters. **Provisional coverage gap:** left. The watch is not closed, so this is not yet a settled blindspot finding. ## Factuality profile of the covering outlets These are published factuality ratings of the outlets, not a verdict on whether this story or its claims are true. - low: 1 - mixed: 3 - high: 4 - unknown: 2 - veryHigh: 1 ## Verification scope This page compares coverage and scores the source reporting. It is not a ClaimReview verdict on whether the underlying event or claim is true. ## Original reporting this was written from - [Common Dreams](https://commondreams.org/news/eric-cantor-phrma) — 'A Match Made in Hell': Former GOP House Leader to Head Big Pharma Lobby - [Washington Times](https://washingtontimes.com/news/2026/sep/29/former-majority-leader-eric-cantor-named-phrma-ceo) — Former House majority leader named CEO of major pharma lobbying group - [Breitbart](https://breitbart.com/health/2026/09/29/eric-cantor-announced-to-serve-as-president-ceo-of-phrma-organization) — Eric Cantor Announced to Serve as President, CEO of PhRMA Organization - [regionalmedianews.com](https://regionalmedianews.com/news/national/health/us-drug-lobby-group-phrma-names-former-house-leader-cantor-as-ceo) — US drug lobby group PhRMA names former House leader Cantor as CEO - Regional Media News - [BizToc](https://biztoc.com/x/cff95909d627b6ea) — Pharma's new top lobbyist is former Majority Leader Eric Cantor - [CDR – Chain Drug Review](https://chaindrugreview.com/phrma-selects-eric-cantor-to-lead-organization-as-next-president-and-ceo) — PhRMA selects Eric Cantor to lead organization as next president and CEO - [The Daily Caller](https://dailycaller.com/2026/09/29/eric-cantor-phrma-president-ceo) — One Of The Biggest Swamp Creatures Takes The Helm Of Drug Lobbying Giant PhRMA - [thedailybs.com](https://thedailybs.com/2026/09/29/eric-cantor-takes-the-helm-of-drug-lobbying-giant-pharma) — Eric Cantor takes the helm of drug lobbying Giant Pharma - The Daily Bo Snerdley - [WTVB](https://wtvbam.com/2026/09/29/us-drug-lobby-group-phrma-names-former-house-leader-cantor-as-ceo) — US drug lobby group PhRMA names former House leader Cantor as CEO - [STAT](https://statnews.com/2026/09/29/eric-cantor-named-phrma-ceo) — PhRMA taps Eric Cantor as new CEO - [PR Newswire](https://prnewswire.com/news-releases/phrma-selects-eric-cantor-to-lead-organization-as-next-president-and-ceo-302893279.html) — PhRMA Selects Eric Cantor to Lead Organization as Next President and CEO ## Questions **Who is Eric Cantor and what is his new role?** Eric Cantor is a former US House Majority Leader. He has been named the new president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), a lobbying group for the pharmaceutical industry. **How much did PhRMA spend on lobbying?** According to reports, PhRMA poured $38 million into lobbying efforts. This spending comes amid public pressure to address the affordability of prescription drugs. **What criticisms have been made about Eric Cantor's past?** Critics like Peter Maybarduk of Public Citizen have pointed to Cantor's legislative record regarding drug prices, stating he voted against measures to lower costs. During his time in Congress, Cantor received approximately $900,000 from the pharmaceutical and health product industry. --- MediaBias News — https://mediabias.news. Reproduced from https://mediabias.news/politics/eric-cantor-named-president-and-ceo-of-phrma. Please cite as: MediaBias News, "Eric Cantor named president and CEO of PhRMA", https://mediabias.news/politics/eric-cantor-named-president-and-ceo-of-phrma